entertainment -WSS

entertainment

author：fashion 2025-08-23 23:16:42 - browse：85

a person wearing blue dress conducts a finger prick test on another person in a home setting — coverage from STAT — Adobe

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.

A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to manage diabetes with the help of finger-stick blood glucose readings don’t result in clinically meaningful improvements over standard care. As a result, they don’t reduce health care spending — they drive it up.

“Most of the solutions in this category do not deliver clinical benefits that justify their cost,” Caroline Pearson, executive director of the institute, told STAT. Despite finding that some populations may benefit, the report concludes that current evidence doesn’t support broader adoption for most products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Why CTE doesn’t keep Americans from enjoying the Super Bowl

WSS

Bird flu in milk supply is likely coming from asymptomatic cows

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

MassMutual is introducing free genetic testing for members

MultiPlan and major insurers sued for alleged medical price

Cancer researcher Catriona Jamieson is sending tumors into space

Cancer researcher Catriona Jamieson is sending tumors into space

hotspot

entertainment

explore

How one medical school became remarkably diverse

A protest over insulin prices is seen as a fight for life

Alkermes shareholders re

Top private equity targets in 2023: cardiology, clinical trials, lasers

23andMe had bad news about my health. I wish a person had delivered it

Medical bills so high, Medicare adding extra digits to claim forms

George Santos makes 1st court appearance after pleading not guilty to 13 counts

More tobacco lobbyists active in statehouses

Continuity nursing helped my family in our darkest PICU moments

Top private equity targets in 2023: cardiology, clinical trials, lasers

hotspot

Texas Medical Board asked to define abortion emergency exception

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Top private equity targets in 2023: cardiology, clinical trials, lasers

Why rehabilitation engineers need to center patients in their research

After traumatic brain injury, life support decisions can use more time

Gene therapy for Afghan refugees’ infant will be fully covered

leisure time

Wikipedia

Wikipedia

knowledge